RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Translational Medicine"
DOI: 10.1186/s12967-019-1878-3
Abstract: BackgroundWhile prostate cancer can often manifest as an indolent disease, the development of locally-advanced or metastatic disease can cause significant morbidity or mortality. Elucidation of molecular mechanisms contributing to disease progression is crucial for more… read more here.
Keywords: disease; prostate cancer; cancer; invasiveness ... See more keywords